Clinics in Dermatology
Volume 27, Issue 1 , Pages 116-121 , January 2009

Nevi and melanoma in the pregnant woman

  • Marcia S. Driscoll, MD

      Affiliations

    • Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    • ,
  • Jane M. Grant-Kels, MD

      Affiliations

    • Department of Dermatology, MC-6230, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 860 679 3474; fax: +1 860 679 1267.

References 

  1. Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol. 1982;6:977–998
  2. Parmley T, O'Brien TJ. Skin changes during pregnancy. Clin Obstet Gynecol. 1990;33:713–717
  3. Hu W, Nelson JE, Mohney CA, et al. Malignant melanoma arising in a pregnant African American woman with a congenital blue nevus. Dermatol Surg. 2004;30:1530–1532
  4. Foucar E, Bentley TJ, Laube D, et al. A histopathologic evaluation of nevocellular nevi in pregnancy. Arch Dermatol. 1985;121:350–354
  5. Sanchez JL, Figueroa LD, Rodriguez E. Behavior of melanocytic nevi during pregnancy. Am J Dermatopathol. 1984;6(Suppl 1):89–91
  6. Ellis DL. Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndrome. J Am Acad Dermatol. 1991;25:467–482
  7. Pennoyer JW, Grin CM, Driscoll MS, et al. Changes in size of melanocytic nevi during pregnancy. J Am Acad Dermatol. 1997;36(3 Pt 1):378–382
  8. Zampino MR, Corazza M, Costantino D, Mollica G, Virgili A. Are melanocytic nevi influenced by pregnancy? A dermatoscopic evaluation. Dermatol Surg. 2006;32:1497–1504
  9. Aktürk AS, Bilen N, Bayrämgürler D, et al. Dermoscopy is a suitable method for the observation of the pregnancy-related changes in melanocytic nevi. J Eur Acad Dermatol Venereol. 2007;21:1086–1090
  10. Wyon Y, Synnerstad I, Fredrikson M, et al. Spectrophotometric analysis of melanocytic naevi during pregnancy. Acta Derm Venereol. 2007;87:231–237
  11. Stolz W, Riemann A, Cognetta AB. ABCD rule of dermoscopy: a new practical method of early recognition of malignant melanoma. Eur J Dermatol. 1994;4:521–527
  12. Moncrieff M, Cotton S, Claridge E, et al. Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. Br J Dermatol. 2002;146:448–457
  13. Haniffa MA, Lloyd JJ, Lawrence CM. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic. Br J Dermatol. 2007;156:1350–1352
  14. Wang SQ, Rabinovitz H, Kopf AW, et al. Current techniques for the in vivo diagnosis of cutaneous melanoma. Clin Dermatol. 2004;22:217–222
  15. Pack GT, Scharnagel IM. The prognosis for malignant melanoma in the pregnant woman. Cancer. 1951;4:324–334
  16. Byrd BF, McGanity WJ. The effect of pregnancy on the clinical course of malignant melanoma. South Med J. 1954;47:196–200
  17. Conybeare RC. Malignant melanoma in pregnancy. Report of three cases. Obstet Gynecol. 1964;24:451–454
  18. Riberti C, Margola G, Bertani A. Malignant melanoma: the adverse effect of pregnancy. Br J Plastic Surg. 1981;34:338–339
  19. Pennington DG. Multiple primary melanoma in pregnancy: a case report. Br J Plastic Surg. 1983;36:260–261
  20. Driscoll MS, Grin-Jorgensen CM, Grant-Kels JM. Does pregnancy influence the prognosis of malignant melanoma?. J Am Acad Dermatol. 1993;29:619–630
  21. Reintgen DS, McCarty KS, Vollmer R, et al. Malignant melanoma and pregnancy. Cancer. 1985;55:1340–1344
  22. McManamny DS, Moss ALH, Pocock PV, et al. Melanoma and pregnancy: a long-term follow-up. Br J Obstet Gynecol. 1989;96:1419–1423
  23. Wong JH, Sterns EE, Kopald KH, et al. Prognostic significance of pregnancy in stage I melanoma. Arch Surg. 1989;124:1227–1231
  24. Slinguff CL, Reintgen DS, Vollmer R, et al. Malignant melanoma arising during pregnancy: a study of 100 patients. Ann Surg. 1990;211:552–559
  25. Daryanani D, Plukker JT, De Hullu JA, et al. Pregnancy and early-stage melanoma. Cancer. 2003;97:2248–2253
  26. MacKie RM, Bufalino R, Morabito A, et al. Lack of effect of pregnancy on outcome of melanoma. Lancet. 1991;337:653–655
  27. Driscoll MS, Grant-Kels JM. Hormones, nevi, and melanoma: an approach to the patient. J Am Acad Dermatol. 2007;57(6):919–931
  28. Lens MB, Rosdahl I, Ahlbom A, et al. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol. 2004;22:4369–4375
  29. O'Meara AT, Cress R, Xing G, et al. Malignant melanoma in pregnancy: a population-based evaluation. Cancer. 2005;103:1217–1226
  30. Lawrence C. Drug management in skin surgery. Drugs. 1996;52:805–817
  31. Gormley DE. Cutaneous surgery and the pregnant patient. J Am Acad Dermatol. 1990;23:269–279
  32. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004;29:564–575
  33. Squatrito RC, Harlow SP. Melanoma complicating pregnancy. Obstet Gynecol Clin North Am. 1998;25:407–416
  34. Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol. 2007;14(1):218–221
  35. Keleher A, Wendt R, Delpassand E, Stachowiak AM, Kuerer HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10:492–495
  36. Schwartz JL, Mozurkewich EL, Johnson TM. Current management of patients with melanoma who are pregnant, want to get pregnant, or do not want to get pregnant. Cancer. 2003;97:2130–2133
  37. Amersi F, Hansen NM. The benefits and limitations of sentinel lymph node biopsy. Curr Treat Options Oncol. 2006;7:141–151
  38. Shapiro RL. Surgical approaches to malignant melanoma: practical guidelines. Dermatol Clin. 2002;20:681–699
  39. Campbell FA, Campbell C. Magnetic resonance imaging for stage IV melanoma during pregnancy. Arch Dermatol. 2006;142:393
  40. Egberts F, Lischner S, Russo P, et al. Diagnostic and therapeutic procedures for management of melanoma during pregnancy: risk for the fetus?. J Dtsch Dermatol Ges. 2006;4:717–720
  41. Beyeler M, Hafner J, Beinder E, et al. Special considerations for stage IV melanoma during pregnancy. Arch Dermatol. 2005;141:1077–1078
  42. Harkin KP, Drumm JE, O'Brien P, et al. Metastatic malignant melanoma in pregnancy. Ir Med J. 1990;83:116–117
  43. Karagas MR, Stukel TA, Dykes J, et al. A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer. 2002;86:1085–1092
  44. Gefeller O, Hassan K, Wille L. Cutaneous malignant melanoma in women and the role of oral contraceptives. Br J Dermatol. 1998;138:122–124
  45. Palmer JR, Rosenberg L, Strom BL, et al. Oral contraceptive use and the risk of cutaneous malignant melanoma. Cancer Causes Control. 1992;3:547–554
  46. Holly EA, Weiss NS, Liff JM. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst. 1983;70:827–831
  47. Beral V, Evans S, Shaw H, et al. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer. 1984;50:681–685
  48. Osterlind A, Tucker MA, Stone BJ, et al. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer. 1988;42:821–824
  49. Gallagher RP, Elwood JM, Hill GB, et al. Reproductive factors, oral contraceptives, and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer. 1985;52:901–907
  50. Holman CDJ, Armstrong BK, Heenan PJ. Cutaneous malignant melanoma in females: exogenous sex hormones and reproductive factors. Br J Cancer. 1984;50:673–680
  51. Naldi L, Altieri A, Imberti GL, et al. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol. 2005;15:545–550
  52. Beral V, Ramcharan S, Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer. 1977;36:804–809
  53. Persson I, Yuen J, Berkvist L, et al. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy: long-term follow-up of a Swedish cohort. Int J Cancer. 1996;67:327–332

PII: S0738-081X(08)00186-7

doi: 10.1016/j.clindermatol.2008.09.009

Clinics in Dermatology
Volume 27, Issue 1 , Pages 116-121 , January 2009

Article Tools